Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1s to be subsidised for patients with the condition, as they are currently prescribed off-label.